23andMe Holding Co (ME)
3.095
-0.14
(-4.18%)
USD |
NASDAQ |
Nov 22, 16:00
3.095
0.00 (0.00%)
After-Hours: 17:31
23andMe Revenue (Quarterly): 44.07M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 44.07M |
| June 30, 2024 | 40.41M |
| March 31, 2024 | 64.03M |
| December 31, 2023 | 44.75M |
| September 30, 2023 | 50.00M |
| June 30, 2023 | 60.86M |
| March 31, 2023 | 92.38M |
| December 31, 2022 | 66.94M |
| September 30, 2022 | 75.66M |
| Date | Value |
|---|---|
| June 30, 2022 | 64.51M |
| March 31, 2022 | 100.56M |
| December 31, 2021 | 56.89M |
| September 30, 2021 | 55.20M |
| June 30, 2021 | 59.24M |
| March 31, 2021 | 88.58M |
| December 31, 2020 | 55.48M |
| September 30, 2020 | 51.80M |
| June 30, 2020 | 48.06M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
40.41M
Minimum
Jun 2024
100.56M
Maximum
Mar 2022
62.19M
Average
58.06M
Median
Revenue (Quarterly) Benchmarks
| RadNet Inc | 461.14M |
| iSpecimen Inc | 2.662M |
| Natera Inc | 439.76M |
| Progyny Inc | 286.62M |
| Delcath Systems Inc | 11.20M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -59.10M |
| Total Expenses (Quarterly) | 103.00M |
| EPS Diluted (Quarterly) | -46.40 |
| Enterprise Value | -42.24M |
| Gross Profit Margin (Quarterly) | 50.84% |
| Profit Margin (Quarterly) | -134.1% |
| Earnings Yield | -2.24K% |
| Normalized Earnings Yield | -1812.23 |